Designing a therapeutic protein that specifically binds its target in drug discovery is a staggering challenge. Traditional workflows are often a painstaking…
Designing a therapeutic protein that specifically binds its target in drug discovery is a staggering challenge. Traditional workflows are often a painstaking trial-and-error process—iterating through thousands of candidates, each synthesis and validation round taking months if not years. Considering the average human protein is 430 amino acids long, the number of possible designs translates to…
